Affordable Insulin Now Act of 2023

12/15/2023, 4:06 PM

Congressional Summary of S 954

Affordable Insulin Now Act of 2023

This bill limits cost-sharing for insulin under private health insurance and establishes a program to provide insulin to individuals without insurance.

Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.

Further, the Department of Health and Human Services (HHS) must enter into agreements with pharmacies or health care providers to provide insulin to individuals without insurance. HHS must pay such pharmacies or providers an amount equal to the difference between the out-of-pocket cost to the individual for a 30-day supply of such insulin products and $35.

Current Status of Bill S 954

Bill S 954 is currently in the status of Bill Introduced since March 23, 2023. Bill S 954 was introduced during Congress 118 and was introduced to the Senate on March 23, 2023.  Bill S 954's most recent activity was Committee on Banking, Housing, and Urban Affairs. Hearings held. as of November 30, 2023

Bipartisan Support of Bill S 954

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
11
Democrat Cosponsors
5
Republican Cosponsors
6
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 954

Primary Policy Focus

Health

Alternate Title(s) of Bill S 954

Affordable Insulin Now Act of 2023Affordable Insulin Now Act of 2023A bill to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals.
Start holding our government accountable!

Comments